Coverage
-
August 29, 2023
A D.C. Circuit panel chastised the U.S. Food and Drug Administration Tuesday for moving the "regulatory goalpost" when the agency denied premarket authorization to Fontem US LLC's unflavored e-cigarettes products, but took no issue with its denial of the company's flavored vapes.
1 other articles on this case.
View all »